Please login to the form below

Not currently logged in
Email:
Password:

dosing

This page shows the latest dosing news and features for those working in and with pharma, biotech and healthcare.

Poseida gets Novartis backing for myleoma CAR-T challenger

Poseida gets Novartis backing for myleoma CAR-T challenger

Poseida’s P-BCMA-101 is currently enrolling patients for a phase 2 registrational trial with initial dosing expected in the first half of 2019, and Novartis yesterday added to its

Latest news

More from news
Approximately 2 fully matching, plus 415 partially matching documents found.

Latest Intelligence

  • Cell and gene therapy Cell and gene therapy

    It’s worth noting that most are regarded as single treatments, with no repeat dosing, and that some are potentially curative of diseases with no current Standard of Care.

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    Editas Medicine and partner Allergan plan to initiate a phase 1/2 clinical trial this year, with patient dosing set to begin in the second half of 2019.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    The drug matched Soliris for efficacy with a trend towards superiority and has improved dosing.

  • How can pharma build bridges with HCPs online? How can pharma build bridges with HCPs online?

    The programme enabled users to click through to a landing page with content specific to the product’s indications and dosing regimens, plus external links to NICE guidance, clinical data and

  • How Augmented reality is disrupting healthcare How Augmented reality is disrupting healthcare

    Differentiation with AR could highlight better efficacy, address new uses or dosing, or build awareness by leveraging an emotional aspect of the product.

More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics